Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Results 1-11 of 11 for your search:
Start Over
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: CDR0000577892, NCI-2015-01484, NCI-2014-01372, SINGAPORE-07-32-LGI, SINGAPORE-ASCOLT, SINGAPORE-ICR-02, ICR-02, NCT00565708
PEG-Interferon Alfa-2a or Hydroxyurea in Treating Patients With High Risk Polycythemia Vera or High Risk Essential Thrombocythemia
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MPD-RC 112, NCI-2012-00269, NCT01259856
Enoxaparin or Aspirin in Preventing Blood Clots in Patients with Cancer and Stroke
Status: Active
Phase: Phase II, Phase I
Type: Supportive care
Age: 18 to 85
Trial IDs: 12-264, NCI-2013-00104, NCT01763606
PEG-interferon Alfa-2a in Treating Patients With High Risk Polycythemia Vera or High Risk Essential Thrombocythemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MPD-RC 111, NCI-2012-00268, 111, NCT01259817
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 1403269898, NCI-2015-00061, HHSN2612012000311, N01-CN-2012-00031, UAZ2013-02-01, NCT02348203
Metformin Hydrochloride and Aspirin in Treating Patients with Hormone-Dependent Prostate Cancer That Has Progressed after Surgery or Radiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 081501, NCI-2015-00397, NCT02420652
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients with Subsolid Lung Nodules
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 50 and over
Trial IDs: MDACC-2013-0732, NCI-2014-01311, 2013-004862-32, 2013-0732, EIO 833/13F, HHSN261201200034I, IEO 37, IEO-833/13F, IEO 833/13F (IEO37), N01-CN-2012-00034, NCT02135497, TO-RFP A, MDA2013-01-01, NCT02169271
Aspirin in Preventing Disease Recurrence in Patients with Barrett Esophagus after Successful Elimination by Radiofrequency Ablation
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 75
Trial IDs: 2015-0819, NCI-2015-01265, 2013-0819, HHSN261201200034I, N01-CN-2012-00034, MDA2013-02-02, NCT02521285
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: VICC THN 1227, NCI-2012-01800, NCT01707823
Aspirin with or without Simvastatin in Preventing Cancer-Associated Blood Clots in Patients with Solid Tumors
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: CASE8Y14, NCI-2014-02356, NCT02285738
Aspirin in Preventing Colorectal Cancer in Patients Who Have Undergone Colonoscopy and Adenoma Removal
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 to 80
Trial IDs: 14-496, NCI-2015-00626, NCT02394769
Start Over